FH and familial hypercholesterolemia: While we agree that an extreme PGSLDL-C in variant-negative individuals can approach some clinically-relevant hypercholesterolemia variants, we did not find evidence that an extreme PGSLDL-C is equivalent to rare pathogenic variants in two canonical FH genes, which have specialized guidelines for screening and clinical management30.